Sort by
Refine Your Search
-
temporal variability, and how they contribute to the total emissions. This may reduce emissions of methane. The opportunity Admission to RMIT University PhD program A four-year scholarship valued at $47,000
-
cryoprotectants and tailored freezing protocols to enable cell survival. Cryopreservation is particularly vital to assisted reproductive technologies for both humans and livestock. Unfortunately, post
-
and the contact details of two referees. Prospective candidates will be invited to submit a full application for admission to the PhD Biomedical Science (DR227). Scholarship applications will only be
-
The proposed 2D photocatalysts are expect to change the traditional way of design artificial photocatalysts. Expected outcomes of this project include fabrication of soft 2D plasmonic photocatalyst
-
This project is aimed at developing platforms to provide security in the post-quantum era. The project aims to incorporate quantum technologies, including quantum machine learning and quantum
-
textiles. The Program includes: Admission to a university PhD program. Supervision by the participating university, CSIRO, and an industry partner. A four year scholarship package totalling approximately
-
In addition to the Industry PhD Program Scholarship of $34,000 pa (GST exempt, indexed annually at 3%), there is an industry top-up component valued at $12,000 pa (not indexed). As such
-
This PhD scholarship is for candidates interested in developing culturally inclusive AI by creating methods and datasets to align large language models with global social and legal norms. This PhD
-
PhD Scholarship in Integrated Photonics for Telecommunication, Biosensing and Precision Measurements
PhD projects in the area of biosensing, communication and precision measurements. Detailed PhD project descriptions that can be found on our webpage (InPAC). To pursue these projects, we are looking
-
map epigenetic changes that promote age-related immune dysfunction, in the context of human vaccination trials, as well as cancer human clinical trials. Specifically, as part of human clinical trial